Clinical trial
Dose-finding Study of SPP100 in Essential Hypertension
NCT00311012 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dose-finding Study of SPP100 in Essential Hypertension
- Lead sponsor
- Novartis
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2004
- Completion date
- March 31, 2005
- Enrollment
- 445 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.